Correlation Between Monopar Therapeutics and CHARLES
Specify exactly 2 symbols:
By analyzing existing cross correlation between Monopar Therapeutics and CHARLES SCHWAB PORATION, you can compare the effects of market volatilities on Monopar Therapeutics and CHARLES and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Monopar Therapeutics with a short position of CHARLES. Check out your portfolio center. Please also check ongoing floating volatility patterns of Monopar Therapeutics and CHARLES.
Diversification Opportunities for Monopar Therapeutics and CHARLES
-0.2 | Correlation Coefficient |
Good diversification
The 3 months correlation between Monopar and CHARLES is -0.2. Overlapping area represents the amount of risk that can be diversified away by holding Monopar Therapeutics and CHARLES SCHWAB PORATION in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CHARLES SCHWAB PORATION and Monopar Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Monopar Therapeutics are associated (or correlated) with CHARLES. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CHARLES SCHWAB PORATION has no effect on the direction of Monopar Therapeutics i.e., Monopar Therapeutics and CHARLES go up and down completely randomly.
Pair Corralation between Monopar Therapeutics and CHARLES
Given the investment horizon of 90 days Monopar Therapeutics is expected to generate 30.65 times more return on investment than CHARLES. However, Monopar Therapeutics is 30.65 times more volatile than CHARLES SCHWAB PORATION. It trades about 0.39 of its potential returns per unit of risk. CHARLES SCHWAB PORATION is currently generating about 0.24 per unit of risk. If you would invest 2,446 in Monopar Therapeutics on November 9, 2024 and sell it today you would earn a total of 2,265 from holding Monopar Therapeutics or generate 92.6% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 95.24% |
| Values | Daily Returns |
Monopar Therapeutics vs. CHARLES SCHWAB PORATION
Performance |
| Timeline |
| Monopar Therapeutics |
| CHARLES SCHWAB PORATION |
Monopar Therapeutics and CHARLES Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Monopar Therapeutics and CHARLES
The main advantage of trading using opposite Monopar Therapeutics and CHARLES positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Monopar Therapeutics position performs unexpectedly, CHARLES can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CHARLES will offset losses from the drop in CHARLES's long position.| Monopar Therapeutics vs. Anebulo Pharmaceuticals | Monopar Therapeutics vs. Acrivon Therapeutics, Common | Monopar Therapeutics vs. Pmv Pharmaceuticals | Monopar Therapeutics vs. Molecular Partners AG |
| CHARLES vs. MGIC Investment Corp | CHARLES vs. AG Mortgage Investment | CHARLES vs. Black Hills | CHARLES vs. Shenzhen Investment Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Complementary Tools
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |